The latest ovarian cancer news and blogs from Target Ovarian Cancer, including fundraising, campaigns, research and support news, and blogs from people affected by ovarian cancer. Scroll down for our events listings, including support and fundraising events.

Information is correct at the time of publication, please note information in historical news stories around drug availability or statistics may not still be relevant.

News
Niraparib approved for women in Scotland
Monday 13 August 2018
After becoming available in England and Wales in June, gamechanging new ovarian cancer drug niraparib (Zejula®) was today approved by the Scottish Medicines Consortium (SMC). Niraparib works by stopping cancer cells from repairing themselves, effectively crippling them. New targeted treatments,...
News
Major breakthrough in ovarian cancer treatment to benefit thousands
Friday 1 June 2018
The National Institute for Health and Care Excellence (NICE) today approved a revolutionary new ovarian cancer drug for use in England on the Cancer Drugs Fund. Niraparib (Zejula®) works by stopping cancer cells from repairing themselves, effectively crippling them. New targeted treatments, so-...
Blog
Doctor writing a prescription
Friday 1 June 2018
The National Institute for Health and Care Excellence (NICE) has approved a revolutionary new ovarian cancer drug for use in England on the Cancer Drugs Fund (CDF). We, together with our supporters, have worked hard to campaign for this announcement. I know what this means for women who can now...
Blog
Jane
Thursday 31 May 2018
Jane Howarth, 54 from Manchester, was diagnosed with advanced ovarian cancer in 2015. She has been taking niraparib for nine months. This is her story in her own words... “Every night I swallow two pills to control my advanced, recurrent ovarian cancer. The cancer I am told is now incurable. The...